Kodiak Sciences Inc (KOD)

Etorro trading 970x250
Kodiak Sciences Inc (KOD) Logo

About Kodiak Sciences Inc

Kodiak Sciences Inc., a clinical stage biopharmaceutical company, engages in researching, developing, and commercializing therapeutics to treat retinal diseases in the United States and international markets. Its lead product candidate is KSI-301, a vascular endothelial growth factor (VEGF)-biological agent that is in Phase 1b clinical study to treat wet age-related macular degeneration (AMD) and diabetic retinopathy, including diabetic macular edema, as well as for macular edema due to retinal vein occlusion. The company’s preclinical stage product candidate includes KSI-501, a bispecific anti-interleukin 6/VEGF bioconjugate conjugate to treat neovascular retinal diseases with an inflammatory component. Its early research pipeline includes KSI-601, a triplet inhibitor for the treatment of multifactorial retinal diseases, such as dry AMD and the neurodegenerative aspects of glaucoma. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was founded in 2009 and is based in Palo Alto, California. Address: 1200 Page Mill Road, Palo Alto, CA, United States, 94304

Kodiak Sciences Inc News and around…

Latest news about Kodiak Sciences Inc (KOD) common stock and company :

Stocks With Rising Relative Strength: Kodiak Sciences
18 Oct, 2021 FinancialContent

Kodiak Sciences shows rising price performance, earning an upgrade to its IBD Relative Strength Rating

We're Hopeful That Kodiak Sciences (NASDAQ:KOD) Will Use Its Cash Wisely
11 Oct, 2021 Yahoo! Finance

We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...

Last Week's Notable Insider Buys Included Evergy, Frontier Communications And More
02 Oct, 2021 FinancialContent

Insider buying can be an encouraging signal for potential investors, especially when markets are uncertain. The week's ...

Kodiak Sciences Shows Rising Relative Strength; Still Shy Of Key Threshold
28 Sep, 2021 FinancialContent

Kodiak Sciences shows improving price performance, earning an upgrade to its IBD Relative Strength Rating

Kodiak Sciences Sees Relative Strength Rating Climb To 73
20 Sep, 2021 FinancialContent

Kodiak Sciences shows improving price performance, earning an upgrade to its IBD Relative Strength Rating

The Past Week's Notable Insider Buys: Continental Resources, Oscar Health, And More
18 Sep, 2021 FinancialContent

With earnings-reporting season over, many insiders are free once more to buy or sell shares. Here are a few of the most noteworthy insider purchases that were reported in the past week.

The Past Week's Notable Insider Buys: Continental Resources, Oscar Health And More
18 Sep, 2021 FinancialContent

Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs. The ...

Analysts Anticipate ESGV Will Reach $92
14 Sep, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Vanguard ESG US.

The Past Week's Notable Insider Buys: Chipotle, Krispy Kreme, Petco Health And More
11 Sep, 2021 FinancialContent

Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs. Some ...

Notable Kodiak Sciences Insider Makes $5.37 Million Buy
10 Sep, 2021 Yahoo! Finance

Julian Baker, Director at Kodiak Sciences (NASDAQ:KOD), made a large insider buy on September 7, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Tuesday showed that Baker purchased 57,501 shares of Kodiak Sciences at a price of $93.12 per share. The total transaction amounted to $5,365,227. Baker now owns a total of 14,412,551 of Kodiak Sciences worth, 1,439,237,342. Kodiak Sciences shares are trading up 2.46% at $99.86 at the tim

3 Stocks Insiders Are Buying
10 Sep, 2021 FinancialContent

When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. ...

Kodiak Sciences Inc. (KOD) Up 15.7% Since Last Earnings Report: Can It Continue?
08 Sep, 2021 Yahoo! Finance

Kodiak Sciences Inc. (KOD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Kodiak Sciences Shows Improved Relative Price Performance; Still Shy Of Benchmark
08 Sep, 2021 FinancialContent

A Relative Strength Rating upgrade for Kodiak Sciences shows improving technical performance. Will it continue?

Stocks Generating Improved Relative Strength: Kodiak Sciences
02 Sep, 2021 FinancialContent

Kodiak Sciences shows improving price performance, earning an upgrade to its IBD Relative Strength Rating

Kodiak Sciences Announces New Long-Term Performance Incentive Plan
01 Sep, 2021 Yahoo! Finance

Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high-prevalence retinal diseases, today announced new seven-year performance stock option awards under a Long-Term Performance Incentive Plan (LTPIP) for named executive officers (NEOs) as well as other eligible Kodiak employees, subject to stockholder approval of the LTPIP at a special meeting expected to be held in October.

Kodiak Sciences to Present at the Morgan Stanley 19th Annual Global Healthcare Conference
31 Aug, 2021 Yahoo! Finance

Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases, announced today that management will present at the virtual Morgan Stanley 19th Annual Global Healthcare Conference on Tuesday, September 14, 2021, at 8:45 a.m. Pacific Time (11:45 a.m. Eastern Time).

The Past Week's Notable Insider Buys Include AppLovin, Cricut, Biotechs, And More
21 Aug, 2021 FinancialContent

With earnings-reporting season all but over, many insiders are free once more to buy or sell shares. Here are a few of the most noteworthy insider purchases that were reported in the past week.

The Past Week's Notable Insider Buys Included AppLovin, Cricut, Biotechs And More
21 Aug, 2021 FinancialContent

Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs. Some ...

4 Stocks Insiders Are Buying
20 Aug, 2021 FinancialContent

When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. ...

Commit To Buy Kodiak Sciences At $65, Earn 33.7% Annualized Using Options
19 Aug, 2021 FinancialContent

Investors considering a purchase of Kodiak Sciences Inc (KOD) stock, but cautious about paying the going market price of $87.26/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2022 put at the $65 strike, which has a bid at the time of this writing of $9.30..

The Past Week's Notable Insider Buys: ConocoPhillips, Cricut, Energy Transfer And More
14 Aug, 2021 FinancialContent

Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs. Some ...

Kodiak Sciences (KOD) Q2 Earnings Lag, Eye Candidate in Focus
10 Aug, 2021 Yahoo! Finance

Kodiak Sciences (KOD) reports wider-than-expected loss for the second quarter of 2021. Pipeline development remains in focus for the company.

Kodiak Sciences Announces Second Quarter 2021 Financial Results and Recent Business Highlights
09 Aug, 2021 Yahoo! Finance

Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases, today reported business highlights and financial results for the second quarter ended June 30, 2021.

Is This Mid-Cap Biotech Stock a Buy Now?
29 Jul, 2021 FinancialContent

This mid-cap growth stock could be a long-term winner.

Were Hedge Funds Right About Selling Kodiak Sciences Inc (KOD)?
28 Jul, 2021 Yahoo! Finance

Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end of September. At Insider Monkey, we follow nearly 900 active hedge funds and notable investors and by analyzing their 13F filings, we can determine the stocks that they are […]

Kodiak Sciences Has Declined $125M Funding From Baker Bros Citing Strong Balance Sheet
23 Jul, 2021 FinancialContent

In December 2019,Kodiak Sciences Inc(NASDAQ: KOD) entered into a funding agreement withBaker Bros Advisors LP, ...

The 20 best-performing IPOs of the past three years have returned up to 1,477%
24 Jun, 2021 FinancialContent

These stock-market winners include BioNTech, Zoom, CrowdStrike and Nio.

Sum Up The Parts: ESGV Could Be Worth $86
22 Jun, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Vanguard ESG US.

Kodiak Sciences Becomes Oversold (KOD)
09 Jun, 2021 FinancialContent

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100..

Why Is Kodiak Sciences Inc. (KOD) Down 4% Since Last Earnings Report?
09 Jun, 2021 Yahoo! Finance

Kodiak Sciences Inc. (KOD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Kodiak Sciences Inc (KOD) is a NASDAQ Common Stock listed in , ,

970x250